Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared With Guided Ultrasound Gel
NCT ID: NCT02819713
Last Updated: 2016-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Lidocaine Gel and Cold Lidocaine Gel on Pain in Patients Who Had Prostate Biopsy With Transrectal Ultrasound
NCT06429046
The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate Biopsy
NCT06998121
Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events
NCT00923416
Pain and Anxiety During Transrectal Prostate Biopsy
NCT05358223
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
NCT06258486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There will be three moments of pain measurements; Prior to het prostate biopsy. Immediately after the prostate biopsy. And five to thirty minutes after the prostate biopsy, when the patient is dressed and before the patient goes home.
Primary endpoint Pain measured by the Numeric Rating Scale
Secondary endpoints
* Age of patient
* Previous prostate biopsy
* The number of biopsies taken
* Presence of prostate cancer
* Other complications as after prostate biopsy
The prostate biopsy will be performed by a urologist working at the outpatient clinic of Rijnstate. The ultrasound equipment that will be used during prostate biopsy is Aloka ProSound SSD-3500 or Aloka ProSound SSD or SV-3500 SX.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultrasound gel
ultrasound gel
Instillagel
Instillagel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound gel
Instillagel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 40 years old.
* Good knowledge of dutch language
Exclusion Criteria
* disorders of the rectum like hemorrhoids, anal fistula, proctitis, rectal polyps and rectal cancer.
* treated for active urinary tract infection
* known of allergy to lidocaine
* taking antidepressants
* using anaesthetic agents
* neurological disorders such as Parkinsons disease, hernias and spinal cord injury
* treated with radiotherapy for prostate cancer
40 Years
85 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marita van den Berg
Role: PRINCIPAL_INVESTIGATOR
Rijnstate Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate location Arnhem
Arnhem, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL35454.091.11
Identifier Type: OTHER
Identifier Source: secondary_id
LTC-744-040111-Roelofs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.